Active pharmaceutical ingredient exposure
Potent compounds handled during dispensing, granulation and milling require sensitisation monitoring and containment verification.
Pharma sector
Occupational health for pharmaceutical manufacturing
API handling, granulation and cleanroom operations combine potent-compound exposure with strict GMP hygiene requirements. Health surveillance here serves two masters — worker protection and product-safety documentation — and both auditors will ask for the same records.
29
Pharma sites under contract
<60s
Audit evidence pack generation
100%
Cleanroom clearance traceability
Primary hazard
API & cleanroom exposure
GMP-aligned health surveillance
Exposure profile
What your people areactually exposed to
The hazards below drive every test in the pharma protocol. Nothing is included because it is standard — each one answers a specific exposure.
Cleanroom hygiene obligations
Personnel working in classified areas need documented freedom from transmissible infection and skin conditions.
Solvent exposure in wet granulation
Ethanol, IPA and acetone use introduces hepatic and respiratory considerations in formulation blocks.
Respiratory sensitisation
Certain APIs act as sensitisers; early detection depends on baseline lung function and symptom tracking.
Examination protocol
The test panel, andthe reason for each test
This is the panel an inspector will ask you to justify. Every row states the exposure it answers and the cycle it runs on.
| Test | Why it is in the panel | Frequency |
|---|---|---|
| Sensitisation screening | Potent API handling | Annual |
| Complete blood count, LFT | Compound and solvent exposure | Annual |
| Spirometry (PFT) | Respiratory sensitisers | Annual |
| Skin and nail assessment | Cleanroom hygiene clearance | Every 6 months |
| Swab clearance where indicated | Classified-area entry | As per SOP |
Statutory basis
What the law expectsof this sector
We prepare the registers and evidence in these formats as part of the programme — not as an add-on when an inspection is announced.
Factories Act 1948, Section 41-C — hazardous process medical examination
Schedule M — personnel health, clothing and hygiene requirements
WHO-GMP personnel health records for classified-area staff
Regulatory inspection readiness — USFDA, EU-GMP and MHRA documentation expectations
Other sectors we run protocols for
Corporate enquiry
Ready to simplify corporate employee healthcare?
Share your workforce profile and receive a written proposal within 48 hours — protocol design, plant-wise scope, camp schedule and commercials, reviewed by an occupational physician.